about
Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primatesRecently emerged swine influenza A virus (H2N3) causes severe pneumonia in Cynomolgus macaquesNasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in miceInfection with MERS-CoV causes lethal pneumonia in the common marmosetThe Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivoVesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primatesEffective post-exposure treatment of Ebola infectionViral hemorrhagic fevers: advancing the level of treatmentCurrent ebola vaccinesLethal influenza virus infection in macaques is associated with early dysregulation of inflammatory related genesDurability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primatesMucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responsesDevelopment of a new vaccine for the prevention of Lassa fever.Personal protective equipment for filovirus epidemics: a call for better evidenceEbola haemorrhagic feverTyro3 family-mediated cell entry of Ebola and Marburg virusesAntibody-dependent enhancement of Ebola virus infectionIntracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins.Ebola virus vaccines: an overview of current approachesAnimal models for highly pathogenic emerging virusesThe Syrian hamster model of hantavirus pulmonary syndromeComparison of the pathogenicity of Nipah virus isolates from Bangladesh and Malaysia in the Syrian hamsterFoodborne transmission of nipah virus in Syrian hamstersEbola virus RNA editing depends on the primary editing site sequence and an upstream secondary structureAntibody quality and protection from lethal Ebola virus challenge in nonhuman primates immunized with rabies virus based bivalent vaccinePanmicrobial Oligonucleotide Array for Diagnosis of Infectious DiseasesAnalysis of the complete genome of the tick-borne flavivirus Omsk hemorrhagic fever virusAberrant innate immune response in lethal infection of macaques with the 1918 influenza virusAn animal model for the tickborne flavivirus--Omsk hemorrhagic fever virusNanopore Sequencing as a Rapidly Deployable Ebola Outbreak ToolEbola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-20152009 pandemic H1N1 influenza virus elicits similar clinical course but differential host transcriptional response in mouse, macaque, and swine infection modelsEffective Chemical Inactivation of Ebola VirusRecent advances in research on Crimean-Congo hemorrhagic fever.Progress towards the treatment of Ebola haemorrhagic fever.Emerging and re-emerging infectious diseases.Immunobiology of Ebola and Lassa virus infections.Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection.African green monkeys recapitulate the clinical experience with replication of live attenuated pandemic influenza virus vaccine candidates.
P50
Q21090120-785E2026-92EE-45D0-AA4A-7A94D5FEB8F9Q21090889-63F2224D-C441-41D7-A3E9-FBBDCDE60400Q21092172-AF64754F-7731-453E-827E-B9113950B8F2Q21131359-177079B5-AA89-49B5-9532-C22A912BB874Q21131393-3215AD7B-92D5-4493-AAF3-5F41EE6680B9Q21131585-8D721355-6961-44EF-B551-1E389D391185Q21131616-FAB62B5E-812A-47C0-8EA6-618CD03058FBQ21245298-9B3528B6-0E98-498F-A6E9-3EB9F5ED5794Q21534720-E5FB98D7-113B-4CFE-80B6-83170C83BE95Q21559413-35C3E170-AAC3-4725-8EEE-68BFD220C583Q21559476-5649EE23-8137-4446-AC47-B9C1EF632879Q21562420-46E52E4C-7A8B-49AA-A2EC-6A4FEC1F3B9EQ21563440-71E7463A-E740-44F4-A18C-B843AFA74249Q23910096-4A5D3959-786F-4A4C-93F8-19CB3A2C8BDFQ24629338-D809B740-EE0F-49E4-9510-0595012E98E6Q24670567-12813D5E-2E1D-4442-BC7B-86A7B337E2ECQ24683154-6E725843-79B4-4D0A-82B5-261C9537F04DQ24800792-9664ADD2-4FD9-4AAF-9C63-14752117AF98Q26999232-1B46B594-5A6D-4A99-918D-2DF3D0AF7C48Q27004147-65F69634-B960-4FFE-B699-BC9C2C0D6B23Q27027405-631AB596-CDE4-4F7A-B90B-FE5D6AC0DC2CQ27305274-D822F19D-BD11-4E05-8D40-3C1F66790B27Q27329845-9A438686-FE7E-410C-9E0F-5AEB2D592816Q27332250-A652F913-30BA-4D58-BD05-B93091BBE407Q27334697-AC7C8441-D7BE-4D63-9735-51DF9C789416Q27489133-8891BA06-F798-41F4-8AAA-BD66B0F2FAD5Q28204538-7E5F9F09-6497-4A25-93B0-E1A2BE1EC2CCQ28283850-AAE92FE6-8338-4982-8BFA-F60AAFFE45BDQ28297951-EEDD63B3-95C3-471F-80CD-A9FC0E5ECF6FQ28385526-64B7331F-DE80-46D1-A485-9DF7A22B6292Q28390874-093BAE08-E4B6-48C8-BE2D-E43B1ED35784Q28392427-BACCAA83-785D-488A-9705-B8E15A6BFAFCQ28829232-5E300261-A857-4313-8364-9FE3B39D5E06Q30205763-3B73F3A3-1FB4-412F-B58B-EF7B10D596DDQ30230272-9920C283-6595-4AD6-96A8-0F28F8AD539BQ30233468-600736C2-410B-4438-B04F-8CBABCDC71FAQ30238887-4538A210-D6F2-4F5F-9871-6D61F3D903CFQ30343761-C1F2EEB8-98D2-4A48-AD11-5AA4AD45BE90Q30361939-7FC58AF7-4B57-42BC-B7FB-F255640AC4A5Q30362332-1EAA82A3-303B-424E-B370-7D53374D271E
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
研究者
@zh
name
Heinz Feldmann
@ast
Heinz Feldmann
@en
Heinz Feldmann
@es
Heinz Feldmann
@nl
type
label
Heinz Feldmann
@ast
Heinz Feldmann
@en
Heinz Feldmann
@es
Heinz Feldmann
@nl
prefLabel
Heinz Feldmann
@ast
Heinz Feldmann
@en
Heinz Feldmann
@es
Heinz Feldmann
@nl
P214
P244
P106
P21
P214
P244
nb2004009557
P31
P496
0000-0001-9448-8227
P7859
lccn-nb2004009557